FindTrial
Sign In

IV Cocaine Abuse: A Laboratory Model - 3

IV Cocaine Abuse: A Laboratory Model

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000214
Enrollment
0
Registered
1999-09-21
Start date
1992-01-31
Completion date
1993-01-31
Last updated
2015-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

intravenous abuse

Brief summary

The purpose of this study is to evaluate the effects of buprenorpine on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.

Interventions

DRUGBuprenorphine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Columbia University
CollaboratorOTHER
New York State Psychiatric Institute
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Direct cocaine effects (caridio, subjective)—
Interaction of coc/bup on cardio measures—
Ineraction of coc/bup on coc's subjective effects—
Effects of buprenorphine on cocaine craving—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026